Skip to main content
Premium Trial:

Request an Annual Quote

Gary McMaster, Peter Kissinger, William Hunt, Jack Gill, Steve Garger, Gregory Pogue, Earl White, Gary Garrigues


Gary McMaster has been appointed CSO of Fremont, Calif.-based GenoSpectra. He joins the company from Eli Lilly, where he was director of target discovery and systems biology research. Previously, he was senior director of molecular biology at Pfizer, and he spent 10 years at Novartis and Ciba-Geigy. He also held research management positions at the Max Planck Institute for Immunology and at Hoffman-La Roche Pharmaceuticals. McMaster received a PhD in developmental biology from the Swiss Institute for Experimental Cancer Research.


The Indiana Proteomics Consortium has appointed three new members to its board of directors: Peter Kissinger, William Hunt, and Jack Gill.

Kissinger currently serves as chairman and CEO of BioAnalytical Systems, and holds a faculty position in bioanalytical chemistry at Purdue University. In 1974 he founded BioAnalytical Systems, a manufacturer of instrumentation and developer of software for biomedical and chemical research. Kissinger joined the faculty at Purdue in 1975.

Hunt is chairman of Hunt Capital Partners, an Indianapolis-based venture capital firm. He also served as chairman and CEO of Arvin, a global manufacturer of automotive components, and most recently held the position of vice chairman and president of ArvinMeritor, a global supplier of integrated systems, modules, and components for light vehicle, commercial truck, and trailer manufacturers.

Gill, a member of the faculty of Harvard Medical School and president of the Gill Foundation of Texas, also serves as an advisor to the Center for the Integration of Medicine and Innovative Technologies, a partnership between Harvard, MIT, and Harvard’s teaching hospitals. Gill has held the position of executive vice president of Spectra Physics, and in 1981 founded Vanguard Ventures, a Silicon Valley high-tech venture capital firm.


Large Scale Biology Corporation, in addition to reorganizing its management structure into three distinct business units with their own cost structure, has also announced the following executive promotions: Steve Garger, vice president for biomanufacturing; Gregory Pogue, vice president for R&D; Earl White, vice president for R&D; Gary Wolfe, vice president for bioinformatics and genomics; and Gary Garrigues, senior counsel for contracts and SEC affairs.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.